Combined treatment modality for intracranial germinomas: results of a multicentre SFOP experience. Société Française d'Oncologie Pédiatrique.

Bouffet, E; Baranzelli, M C; Patte, C; Portas, M; Edan, C; Chastagner, P; Mechinaud-Lacroix, F; Kalifa, C

Bouffet, E; Baranzelli, M C; Patte, C; Portas, M; Edan, C; Chastagner, P; Mechinaud-Lacroix, F; Kalifa, C.

Affiliation

Bouffet E; Service d'Oncologie Pédiatrique, Centre L Bérard, Lyon, France.

Br J Cancer ; 79(7-8): 1199-204, 1999 Mar.

Article in En | MEDLINE | ID: mdl-10098759

Subject(s)

Antineoplastic Agents/therapeutic use; Brain Neoplasms/drug therapy; Brain Neoplasms/radiotherapy; Germinoma/drug therapy; Germinoma/radiotherapy; Adolescent; Adult; Brain Neoplasms/metabolism; Brain Neoplasms/surgery; Carboplatin/therapeutic use; Child; Child, Preschool; Chorionic Gonadotropin, beta Subunit, Human/metabolism; Combined Modality Therapy; Disease-Free Survival; Female; Follow-Up Studies; Germinoma/metabolism; Germinoma/surgery; Humans; Ifosfamide/therapeutic use; Male; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Germinoma / Antineoplastic Agents Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Language: En Journal: Br J Cancer Year: 1999 Document type: Article

Fulltext

XML

PubMed Links

Search on Google